(IP Shipping Address) Advocate Illinois Masonic Medical Center — Chicago, Illinois

(IP Shipping Address) Advocate Illinois Masonic Medical Center is a clinical research site located in Chicago, Illinois, United States 60657.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

(IP Shipping Address) Advocate Illinois Masonic Medical Center has participated in 1 clinical trials.

Therapeutic areas: Post Herpetic Neuralgia.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for (IP Shipping Address) Advocate Illinois Masonic Medical Center?

(IP Shipping Address) Advocate Illinois Masonic Medical Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has (IP Shipping Address) Advocate Illinois Masonic Medical Center conducted?

(IP Shipping Address) Advocate Illinois Masonic Medical Center has 1 clinical trials on record. Their work covers Post Herpetic Neuralgia.

Is (IP Shipping Address) Advocate Illinois Masonic Medical Center accredited by Crixeo Clinical Trials?

(IP Shipping Address) Advocate Illinois Masonic Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about (IP Shipping Address) Advocate Illinois Masonic Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.